Morse Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.85M Sell
9,617
-555
-5% -$563K 1.84% 13
2025
Q4
$10.9M Sell
10,172
-744
-7% -$711K 2.19% 9
2025
Q3
$8.33M Sell
10,916
-35
-0.3% -$26K 1.66% 13
2025
Q2
$8.54M Sell
10,951
-68
-0.6% -$52.8K 1.87% 12
2025
Q1
$9.1M Buy
11,019
+281
+3% +$234K 2.3% 8
2024
Q4
$8.29M Sell
10,738
-281
-3% -$233K 1.89% 13
2024
Q3
$9.76M Buy
11,019
+109
+1% +$98K 2.11% 10
2024
Q2
$9.88M Sell
10,910
-229
-2% -$183K 2.4% 7
2024
Q1
$8.67M Buy
11,139
+701
+7% +$499K 2.21% 10
2023
Q4
$6.08M Sell
10,438
-596
-5% -$348K 1.79% 16
2023
Q3
$5.93M Sell
11,034
-338
-3% -$174K 1.88% 14
2023
Q2
$5.33M Buy
11,372
+1,515
+15% +$635K 1.62% 18
2023
Q1
$3.38M Buy
9,857
+314
+3% +$106K 1.14% 29
2022
Q4
$3.49M Buy
9,543
+2,100
+28% +$745K 1.27% 24
2022
Q3
$2.41M Sell
7,443
-12,980
-64% -$4.11M 0.91% 35
2022
Q2
$6.62M Buy
20,423
+2,978
+17% +$894K 2.12% 11
2022
Q1
$5M Buy
17,445
+2,295
+15% +$591K 1.24% 21
2021
Q4
$4.18M Buy
15,150
+11,150
+279% +$2.83M 0.93% 32
2021
Q3
$924K Buy
4,000
+1,000
+33% +$247K 0.22% 96
2021
Q2
$689K Buy
+3,000
New +$603K 0.17% 103
2019
Q2
Sell
-1,765
Closed -$229K 142
2019
Q1
$229K Buy
+1,765
New +$215K 0.07% 120

Other funds holding LLY

Morse Asset Management's LLY Position: Q1 2026 in Review

Morse Asset Management reduced its Eli Lilly (LLY) stake by 5.5% in Q1 2026, selling an estimated $563K and leaving 9,617 shares worth $8.85M. The position accounts for 1.84% of the portfolio, ranked #13.

Morse Asset Management first reported a position in LLY in Q1 2019 and has held it in 21 quarters since. The position peaked at $10.9M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Morse Asset Management held 9,617 shares of Eli Lilly worth $8.85M as of Q1 2026.
  • Morse Asset Management sold 555 Eli Lilly shares in Q1 2026, an estimated $563K.
  • Eli Lilly made up 1.84% of Morse Asset Management's portfolio in Q1 2026, its #13 holding.
  • Morse Asset Management first reported a position in Eli Lilly in Q1 2019 and has held it in 21 quarters since.
  • Morse Asset Management's Eli Lilly position peaked at $10.9M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Morse Asset Management's 13F filing for Q1 2026, filed 14 May 2026.